Meeting
2013 ASCO Annual Meeting
RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients.
Authors
Robert D. Timmerman
The University of Texas Southwestern Medical Center, Dallas, TX
Robert D. Timmerman , Rebecca Paulus , Harvey I. Pass , Elizabeth Gore , Martin J. Edelman , James M. Galvin , Hak Choy , William Straube , Lucien Alexander Nedzi , Ronald McGarry , Cliff Grant Robinson , Peter B. Schiff , Jeffrey D. Bradley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT00551369
Citation
J Clin Oncol 31, 2013 (suppl; abstr 7523)
DOI
10.1200/jco.2013.31.15_suppl.7523
Abstract #
7523
Poster Bd #
17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
First Author: Gustavo Schvartsman
Poster
2014 ASCO Quality Care Symposium
Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta, Canada.
First Author: Marc Kerba
Poster
2011 ASCO Annual Meeting
Stereotactic body radiation therapy versus high-dose conventional radiation therapy in early-stage NSCLC: A retrospective study on local failure and survival rates.
First Author: S. Jeppesen
Poster
2023 ASCO Annual Meeting
Long-term outcomes of single and five fraction schedules of stereotactic body radiation therapy for early-stage central or peripheral NSCLC: Neither fractionation nor location matter?
First Author: Karen Huang